Literature DB >> 3496414

Human monocyte Arg-Serpin cDNA. Sequence, chromosomal assignment, and homology to plasminogen activator-inhibitor.

A C Webb, K L Collins, S E Snyder, S J Alexander, L J Rosenwasser, R L Eddy, T B Shows, P E Auron.   

Abstract

An LPS-stimulated, human monocyte cDNA library was screened for stimulation-specific clones. One clone (pcD-1214) contained a 1.9-kb pair insert that hybridized to a 2,000-nucleotide mRNA expressed by peripheral blood monocytes, the histiocytic lymphoma cell line U937, and umbilical cord endothelial cells. The 415-amino-acid precursor polypeptide predicted from the cDNA (46,596 molecular weight) has a putative 22-residue signal peptide and approximately 35% homology with members of the serine protease inhibitor (Serpin) superfamily. On the basis of amino acid homology and alignment of COOH-terminal residues within the Serpin-reactive center, the clone pcD-1214 was identified as coding for an Arg-Serpin. Southern blot analysis of human-mouse somatic cell hybrid DNA locates the Arg-Serpin gene on human chromosome 18. A perfect match between amino acid residues 347-376 in this Arg-Serpin and the published sequence of a 30-residue, tryptic peptide from the COOH-terminus of a monocyte plasminogen activator-inhibitor (PAI-2), strongly suggests that the Arg-Serpin encoded by pcD-1214 is PAI-2.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3496414      PMCID: PMC2188630          DOI: 10.1084/jem.166.1.77

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  64 in total

Review 1.  Human plasma proteinase inhibitors.

Authors:  J Travis; G S Salvesen
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

2.  Measurements of the effects that coding for a protein has on a DNA sequence and their use for finding genes.

Authors:  R Staden
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

3.  Monoclonal antibodies to human urokinase identify the single-chain pro-urokinase precursor.

Authors:  G Salerno; P Verde; M L Nolli; A Corti; H Szöts; T Meo; J Johnson; S Bullock; G Cassani; F Blasi
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

4.  A putative signal peptidase recognition site and sequence in eukaryotic and prokaryotic signal peptides.

Authors:  D Perlman; H O Halvorson
Journal:  J Mol Biol       Date:  1983-06-25       Impact factor: 5.469

5.  New M13 vectors for cloning.

Authors:  J Messing
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

6.  Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  1984-01-25       Impact factor: 16.971

7.  Patterns of amino acids near signal-sequence cleavage sites.

Authors:  G von Heijne
Journal:  Eur J Biochem       Date:  1983-06-01

8.  Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells.

Authors:  D J Loskutoff; J A van Mourik; L A Erickson; D Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

9.  Sequence homology between retroviral reverse transcriptase and putative polymerases of hepatitis B virus and cauliflower mosaic virus.

Authors:  H Toh; H Hayashida; T Miyata
Journal:  Nature       Date:  1983 Oct 27-Nov 2       Impact factor: 49.962

10.  Structural requirements of N-glycosylation of proteins. Studies with proline peptides as conformational probes.

Authors:  E Bause
Journal:  Biochem J       Date:  1983-02-01       Impact factor: 3.857

View more
  11 in total

1.  Sequence and molecular characterization of human monocyte/neutrophil elastase inhibitor.

Authors:  E Remold-O'Donnell; J Chin; M Alberts
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

Review 2.  The plasmin-antiplasmin system: structural and functional aspects.

Authors:  Johann Schaller; Simon S Gerber
Journal:  Cell Mol Life Sci       Date:  2010-12-07       Impact factor: 9.261

3.  Expression of (cac)n/(gtg)n simple repetitive sequences in mRNA of human lymphocytes.

Authors:  C Epplen; J T Epplen
Journal:  Hum Genet       Date:  1994-01       Impact factor: 4.132

4.  Regulatory elements involved in constitutive and phorbol ester-inducible expression of the plasminogen activator inhibitor type 2 gene promoter.

Authors:  E Cousin; R L Medcalf; G E Bergonzelli; E K Kruithof
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

Review 5.  The plasminogen-plasmin system in malignancy.

Authors:  H C Kwaan
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

6.  Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitor.

Authors:  T M Antalis; M A Clark; T Barnes; P R Lehrbach; P L Devine; G Schevzov; N H Goss; R W Stephens; P Tolstoshev
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

7.  Expression of plasminogen activator and plasminogen activator inhibitor mRNA in human fibroblasts grown on different substrates.

Authors:  J Varani; R G Sitrin; W Hillegas
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

8.  Facultative polypeptide translocation allows a single mRNA to encode the secreted and cytosolic forms of plasminogen activators inhibitor 2.

Authors:  D Belin; A Wohlwend; W D Schleuning; E K Kruithof; J D Vassalli
Journal:  EMBO J       Date:  1989-11       Impact factor: 11.598

9.  Elastase inhibitor. Characterization of the human elastase inhibitor molecule associated with monocytes, macrophages, and neutrophils.

Authors:  E Remold-O'Donnell; J C Nixon; R M Rose
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

10.  The transcription factor C/EBP-β mediates constitutive and LPS-inducible transcription of murine SerpinB2.

Authors:  Ekemini A Udofa; Brett W Stringer; Padmaja Gade; Donna Mahony; Marguerite S Buzza; Dhananjaya V Kalvakolanu; Toni M Antalis
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.